What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

BACKGROUND: The objective of this research was to examine treatment patterns and health-care costs associated with second-step pharmacotherapy in patients with major depressive disorder (MDD) who initiated monotherapy with a selective serotonin reuptake inhibitor (SSRI) in 2010. METHODS: This claims...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Susan, Classi, Peter, Dennehy, Ellen B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994945/
https://www.ncbi.nlm.nih.gov/pubmed/24645830
http://dx.doi.org/10.1186/1744-859X-13-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994945/
https://www.ncbi.nlm.nih.gov/pubmed/24645830
http://dx.doi.org/10.1186/1744-859X-13-8

Ejemplares similares